Neuroreport 1996-09-02

Effect of the AMPA receptor modulator IDRA 21 on LTP in hippocampal slices.

A Arai, A Guidotti, E Costa, G Lynch

Index: Neuroreport 7(13) , 2211-5, (1996)

Full Text: HTML

Abstract

IDRA 21 (7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide) has been reported to modulate AMPA receptor kinetics and to improve memory in certain animal models. In the present study, its effects on synaptic transmission and long-term potentiation (LTP) were tested in hippocampal slices. IDRA 21 (500 microM) significantly increased the amplitude and halfwidth of field EPSPs. The drug did not affect monosynaptic IPSPs but enhanced disynaptically-induced feedforward IPSPs, presumably by acting on AMPA receptors on interneurons. At concentrations that facilitated synaptic transmission, IDRA 21 promoted the induction of LTP; i.e. full potentiation was obtained with stimulation paradigms that were only partially effective in the absence of drug. The results support the hypothesis that drugs which enhance AMPA receptor-mediated currents facilitate LTP.

Related Compounds

  • 7-Chloro-3,4-dihyd...

Related Articles:

Thermodynamics and structural analysis of positive allosteric modulation of the ionotropic glutamate receptor GluA2.

2012-01-01

[Biochem. J. 441(1) , 173-8, (2012)]

7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide: a partial modulator of AMPA receptor desensitization devoid of neurotoxicity.

1997-06-24

[Proc. Natl. Acad. Sci. U. S. A. 94(13) , 7053-8, (1997)]

IDRA-21, a positive AMPA receptor modulator, inhibits synaptic and extrasynaptic NMDA receptor mediated events in cultured cerebellar granule cells.

2004-06-01

[Neuropharmacology 46(8) , 1105-13, (2004)]

Changes in AMPA receptor-spliced variant expression and shift in AMPA receptor spontaneous desensitization pharmacology during cerebellar granule cell maturation in vitro.

1998-08-01

[J. Mol. Neurosci. 11(1) , 23-41, (1998)]

7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.

1995-01-01

[J. Pharmacol. Exp. Ther. 272 , 300-309, (1995)]

More Articles...